Ramy Sedhom, MD

Ramy Sedhom, MD, Ryan Chow, MD, and Ronac Mamtani, MD, MSCE, discuss dose reducing enfortumab vedotin to improve tolerability, without in patients with bladder cancer

Ramy Sedhom, MD, looks back on his first year of oncology fellowship and shares advice for first-year fellows and trainees.

Caring for patients with cancer requires a change in perspective. The reward is the fight itself, the daily work. It’s the lives we’re able to save and the dignity we’re able to preserve in death. But the grief is not limited to patients or their families. It is also an unaddressed part of the cancer continuum.